Jeremy Gowler
Director/Board Member at Versatope Therapeutics, Inc.
Net worth: - $ as of 2024-04-29
Profile
Mr. Jeremy Gowler is on the Board of Directors at Versatope Therapeutics, Inc. and Vaccine & Infectious Disease Organization.
Mr. Gowler was previously employed as a Chief Executive, Operating & Commercial Officer by Invivyd, Inc., a Vice President-Global Commercial by PaxVax, Inc., a Brand Manager-Marketing by Novartis Pharmaceuticals Canada, Inc., a Director-Medical Affairs by Novartis Vaccines & Diagnostics Services AG, a Senior Director-Marketing by Novartis Vaccines & Diagnostics, Inc., and a Head-Biopharmaceuticals by Sandoz Biopharmaceuticals.
He received his undergraduate degree from the University of Victoria.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INVIVYD, INC.
-.--% | 2023-12-17 | 0 ( -.--% ) | - $ | 2024-04-29 |
Jeremy Gowler active positions
| Companies | Position | Start |
|---|---|---|
Versatope Therapeutics, Inc.
 Versatope Therapeutics, Inc. BiotechnologyHealth Technology Versatope Therapeutics, Inc. is an immuno-therapeutic company based in Lowell, MA. The private company harnesses a customized biotechnology platform to deliver immunity using state-of-the-art synthetic biology and bioinformatics. The company customizes exosome-like vesicles made from probiotics to display targets in a 3D context that activates potent immunity. The company's lead vaccine candidate addresses the need for improved, effective universal influenza vaccines to prevent influenza and other emerging infectious diseases, such as the current COVID-19. The company was founded in 2017 by Christopher Locher and Dave Putnam, and Christopher Locher has been the CEO since 2017. | Director/Board Member | 2020-12-31 |
| Vaccine & Infectious Disease Organization | Director/Board Member | - |
Former positions of Jeremy Gowler
| Companies | Position | End |
|---|---|---|
| INVIVYD, INC. | Chief Executive Officer | 2024-05-29 |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 2017-12-31 |
| Sandoz Biopharmaceuticals | Corporate Officer/Principal | - |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Sales & Marketing | - |
| Novartis Vaccines & Diagnostics Services AG | Chief Tech/Sci/R&D Officer | - |
Training of Jeremy Gowler
| University of Victoria | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INVIVYD, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
| Novartis Vaccines & Diagnostics Services AG | |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Health Technology |
Versatope Therapeutics, Inc.
Versatope Therapeutics, Inc. BiotechnologyHealth Technology Versatope Therapeutics, Inc. is an immuno-therapeutic company based in Lowell, MA. The private company harnesses a customized biotechnology platform to deliver immunity using state-of-the-art synthetic biology and bioinformatics. The company customizes exosome-like vesicles made from probiotics to display targets in a 3D context that activates potent immunity. The company's lead vaccine candidate addresses the need for improved, effective universal influenza vaccines to prevent influenza and other emerging infectious diseases, such as the current COVID-19. The company was founded in 2017 by Christopher Locher and Dave Putnam, and Christopher Locher has been the CEO since 2017. | Health Technology |
| Vaccine & Infectious Disease Organization | |
| Sandoz Biopharmaceuticals |
- Stock Market
- Insiders
- Jeremy Gowler
